Breast cancerCancer controlGLOBOCAN 2008Global cancer burdenLung cancer
Figures from the paper
Abstract (AI)
The global burden of cancer continues to increase largely because of the aging and growth of the world population alongside an increasing adoption of cancer-causing behaviors, particularly smoking, in economically developing countries. Based on the GLOBOCAN 2008 estimates, about 12.7 million cancer cases and 7.6 million cancer deaths are estimated to have occurred in 2008; of these, 56% of the cases and 64% of the deaths occurred in the economically developing world. Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death among females, accounting for 23% of the total cancer cases and 14% of the cancer deaths. Lung cancer is the leading cancer site in males, comprising 17% of the total new cancer cases and 23% of the total cancer deaths. Breast cancer is now also the leading cause of cancer death among females in economically developing countries, a shift from the previous decade during which the most common cause of cancer death was cervical cancer. Further, the mortality burden for lung cancer among females in developing countries is as high as the burden for cervical cancer, with each accounting for 11% of the total female cancer deaths. Although overall cancer incidence rates in the developing world are half those seen in the developed world in both sexes, the overall cancer mortality rates are generally similar. Cancer survival tends to be poorer in developing countries, most likely because of a combination of a late stage at diagnosis and limited access to timely and standard treatment. A substantial proportion of the worldwide burden of cancer could be prevented through the application of existing cancer control knowledge and by implementing programs for tobacco control, vaccination (for liver and cervical cancers), and early detection and treatment, as well as public health campaigns promoting physical activity and a healthier dietary intake. Clinicians, public health professionals, and policy makers can play an active role in accelerating the application of such interventions globally.
Key Findings
1
A substantial proportion of global cancer could be prevented through tobacco control, vaccination, early detection, timely treatment, physical activity, and healthier diets.
2
Breast cancer surpassed cervical cancer as the leading cause of cancer death among females in economically developing countries; lung and cervical cancers each caused 11% of female cancer deaths.
3
Breast cancer was the most frequently diagnosed cancer and leading cause of female cancer death globally, accounting for 23% of cases and 14% of deaths.
4
Developing countries had roughly half the overall cancer incidence of developed countries but generally similar mortality, reflecting poorer survival associated with later diagnosis and limited access to standard treatment.
5
Global cancer burden reached an estimated 12.7 million new cases and 7.6 million deaths in 2008, with 56% of cases and 64% of deaths occurring in economically developing countries.
6
Lung cancer was the leading cancer site among males, representing 17% of new cases and 23% of cancer deaths.
Research Object
Global burden of cancer (worldwide cancer incidence, mortality, and distribution by region and cancer type)
Research Subject
Worldwide cancer incidence, mortality, distribution, survival disparities, temporal shifts, and preventability
Publication Details
Publication Date
2011-02-04
Journal
Publisher
ISSN
Cited by
55275
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai2
Cited by18
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries2024
Review The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge2015
What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases2019
The Enigmatic Epidemiology of Nasopharyngeal Carcinoma2006
Cancer Progress and Priorities: Lung Cancer2019
The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects2020
Physical activity, exercise, and chronic diseases: A brief review2019
Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions2017
Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles2009
The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer2016
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)2019
Gastric cancer: Prevention, screening and early diagnosis2014
Nutrition, Well-Being and Health2012
Liposome and Their Applications in Cancer Therapy2016
The Spectrum of Genetic Mutations in Breast Cancer2015
Review of the Correlation of LAT1 With Diseases: Mechanism and Treatment2020
The Anticancer Potential of Plant-Derived Nutraceuticals via the Modulation of Gene Expression2022
Hepatitis B virus as a risk factor for hepatocellular carcinoma: There is still much work to do2024